×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| VIVO BIO TECH LTD. | NA | NA | NA | NA | 72.5 | 8.56 |
| VISTA PHARMACEUTICALS LTD. | NA | NA | NA | NA | 70.4 | |
| BIOFIL CHEMICALS & PHARMACEUTI | 92.65 | 24.11 | 64.33 | 1.48 | 69.2 | 24.8 |
Vivo Bio tech Ltd., with Security Code 511509, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.4 | 14.4 | 11.6 | 9.0 | 12.7 | 11.6 | 10.1 | 12.0 | 12.2 | 12.3 |
| Expenses | 8.5 | 7.3 | 7.0 | 4.3 | 6.3 | 6.2 | 5.8 | 6.4 | 6.6 | 7.1 |
| Operating Profit | 4.9 | 7.1 | 4.6 | 4.8 | 6.4 | 5.3 | 4.4 | 5.7 | 5.6 | 5.2 |
| OPM % | 36.78% | 49.34% | 39.72% | 52.82% | 50.2% | 46.14% | 43.16% | 47.11% | 45.97% | 42.45% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 | 0.0 | 0.2 |
| Interest | 2.1 | 2.0 | 1.9 | 2.1 | 2.2 | 1.5 | 1.9 | 2.1 | 1.8 | 1.7 |
| Depreciation | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.4 | 2.2 | 2.3 | 2.2 | 2.2 |
| Profit before tax | 0.6 | 2.9 | 0.4 | 0.4 | 1.9 | 1.4 | 0.2 | 5.9 | 1.5 | 1.4 |
| Tax % | -71.1% | -28.6% | -30.2% | -35.8% | -30.8% | -50% | -23.9% | -10.7% | -41.8% | -7.3% |
| Net Profit | 0.2 | 2.0 | 0.3 | 0.2 | 1.3 | 0.7 | 0.2 | 5.3 | 0.9 | 1.2 |
| EPS in Rs | 0.11 | 1.37 | 0.17 | 0.16 | 0.89 | 0.29 | 0.12 | 3.56 | 0.6 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.5 | 14.8 | 11.6 | 9.3 | 12.8 | 11.8 | 10.1 | 12.0 | 12.2 | 12.3 |
| Expenses | 8.6 | 7.6 | 7.1 | 4.4 | 6.5 | 6.4 | 5.8 | 6.4 | 6.7 | 7.3 |
| Operating Profit | 4.9 | 7.1 | 4.5 | 4.9 | 6.4 | 5.4 | 4.4 | 5.6 | 5.5 | 5.0 |
| OPM % | 36.38% | 48.31% | 38.72% | 52.45% | 49.64% | 45.66% | 43.05% | 46.46% | 45.36% | 40.83% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 | 0.0 | 0.2 |
| Interest | 2.1 | 2.0 | 1.9 | 2.1 | 2.2 | 1.5 | 1.9 | 2.1 | 1.8 | 1.7 |
| Depreciation | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.4 | 2.2 | 2.3 | 2.2 | 2.2 |
| Profit before tax | 0.5 | 2.9 | 0.3 | 0.5 | 1.9 | 1.4 | 0.2 | 5.9 | 1.5 | 1.2 |
| Tax % | -72.7% | -28.3% | -43.9% | -29.5% | -30.8% | -48.7% | -25.2% | -10.8% | -43.9% | -8.1% |
| Net Profit | 0.1 | 2.1 | 0.1 | 0.3 | 1.3 | 0.7 | 0.2 | 5.2 | 0.8 | 1.1 |
| EPS in Rs | 0.1 | 1.38 | 0.1 | 0.22 | 0.89 | 0.31 | 0.11 | 3.51 | 0.55 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | -3% |
| 3 Years: | -3% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 11% |
| 3 Years: | 51% |
| TTM: | 200% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 7% |
| 3 Years: | -2% |
| 1 Year: | -8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | -3% |
| 3 Years: | -3% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 10% |
| 3 Years: | 49% |
| TTM: | 188% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 7% |
| 3 Years: | -2% |
| 1 Year: | -8% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|